The development and improvement of standardized reporting frameworks for various entities, including prostate cancer, such as PSMA-RADS version 2.0 and PROMISE V2, represents a substantial advancement in the field of medical imaging and clinical decision-making [26]. The gene discussed is FOLH1; the disease is Familial prostate cancer.